Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Abarquez, Jr., Ramon F. | Cinco, Jude Erric L.
Affiliations: Department of Medicine, Philippine General Hospital‐College of Medicine, University of the Philippines, Manila, Philippines
Note: [] Corresponding author. E‐mail: [email protected].
Abstract: Microcirculation conduit, distribution, exchange and reception vessels usually retain a demand‐dependent vascular–tissue match as well as a nutrient friendly capillary–matrix tissue match. Various stimuli can initiate a vascular–capillary matrix‐tissue mismatch. Counter‐regulatory mechanisms result in hyperplasia or apoptosis. Microvascular disease (MVD) as a consequence or outcome of supply–demand mismatch has clinical therapeutic and prognostic implications in the hypertensive syndrome and coronary artery disease (CAD) cases. Recognition of the role of apoptosis and MVD may initiate a paradigm shift in clinical practice. Digitalis and other anti‐hypertensive agents have anti‐apoptotic action and MVD blunting effects that can control LVH development to reduce congestive heart failure (CHF) progression.
Keywords: Apoptosis, microvascular diseases, cardiovascular diseases, hypertension
Journal: Clinical Hemorheology and Microcirculation, vol. 29, no. 3-4, pp. 157-165, 2003
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]